EXEL · Exelixis, Inc.
$51.24
+0.63 (+1.24%)
At close · Aug 14
Market Cap
$12.70B
Shares
247.78M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$597,800,000
as of 2026-07-03
Program Utilization
20.3%
$152,200,000 used of $750,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-07-03 YTD | $753,326,000 | 10-Q, filed 2026-08-05 | ||
| 2026-01-02 | $947,511,000 | 10-K, filed 2026-02-10 | ||
| 2025-01-03 | $652,033,000 | 10-K, filed 2026-02-10 | ||
| 2023-12-29 | $550,378,000 | 10-K, filed 2026-02-10 | ||
Key facts
CIK
939767
CUSIP
30161Q104
13F (30d)
731 filings
683 filers
Visit website
Investor relations